[Criteria for treating MRSA in sputum].

Area of Science:

• Infectious Diseases
• Microbiology
• Pulmonology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) presents significant challenges in managing airway infections.
• MRSA infections are characterized by complicated disease courses and difficult-to-treat multiple resistances.
• While prevalence is declining, MRSA remains a concern in hospital-acquired, hospital-associated, and community-acquired infections.

Purpose of the Study:

• To review the significance of MRSA in airway infections.
• To discuss the challenges in treatment and the characteristics of different MRSA strains.
• To outline management strategies for MRSA colonization and infection in various airway conditions.

Main Methods:

• Literature review of MRSA epidemiology and clinical significance in airway infections.
• Analysis of pathogenic factors and resistance patterns in different MRSA strains.
• Discussion of anti-infective agents and treatment approaches for MRSA airway infections.

Main Results:

• MRSA infections complicate airway disease management due to resistance.
• Non-nosocomial MRSA strains exhibit distinct pathogenic factors and resistance, often leading to severe disease.
• Effective anti-infectives for MRSA are limited and possess specific toxicities.

Conclusions:

• MRSA remains a critical pathogen in airway infections, demanding specialized management.
• Spontaneous clearance of MRSA colonization occurs in healthy individuals; acute bronchitis is treatable with oral antibiotics.
• Chronic airway infections, such as in bronchiectasis, require comprehensive systemic and local treatment for MRSA elimination.